<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001402'>Hepatocellular carcinoma</z:hpo> (<z:mp ids='MP_0003331'>HCC</z:mp>) is one of the most common and lethal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>It arises from modulation of multiple genes by mutations, epigenetic regulation, noncoding <z:chebi fb="40" ids="33697">RNAs</z:chebi> and translational modifications of encoded proteins </plain></SENT>
<SENT sid="2" pm="."><plain>Although &gt;40% of <z:mp ids='MP_0003331'>HCCs</z:mp> are clonal and thought to arise from <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells (<z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>), the precise identification and mechanisms of <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> formation remain poorly understood </plain></SENT>
<SENT sid="3" pm="."><plain>A functional role of transforming growth factor (TGF)-β signalling in liver and intestinal stem cell niches has been demonstrated through mouse genetics </plain></SENT>
<SENT sid="4" pm="."><plain>These studies demonstrate that loss of TGF-β signalling yields a phenotype similar to a human <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> disorder, <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Insights into this powerful pathway will be vital for developing new therapeutics in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Current clinical approaches are aimed at establishing novel <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> drugs that target activated pathways when the TGF-β <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor pathway is lost, and TGF-β itself could potentially be targeted in <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Studies delineating key functional pathways in <z:mp ids='MP_0003331'>HCC</z:mp> and <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> formation could be important in preventing this disease and could lead to simple treatment strategies; for example, use of <z:chebi fb="27" ids="27300">vitamin D</z:chebi> might be effective when the TGF-β pathway is lost or when wnt signalling is activated </plain></SENT>
</text></document>